Rigel Pharmaceuticals, Inc. (RIGL) stock is higher by 129.34% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives RIGL stock a score of 69 out of a possible 100.
That rank is mainly influenced by a fundamental score of 88. In addition to the average rating from Wall Street analysts, RIGL stock has a mean target price of 8.4. This means analysts expect the stock to add 119.32% over the next 12 months. RIGL's rank also includes a short-term technical score of 83. The long-term technical score for RIGL is 36.
What's Happening with RIGL Stock Today
Rigel Pharmaceuticals, Inc. (RIGL) stock has gained 2.68% while the S&P 500 is higher by 1.07% as of 12:56 PM on Thursday, Apr 15. RIGL is higher by $0.10 from the previous closing price of $3.73 on volume of 2,403,489 shares. Over the past year the S&P 500 is up 49.78% while RIGL is higher by 129.34%. RIGL lost -$0.18 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Rigel Pharmaceuticals, Inc. (RIGL) Stock.
